Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Testosterone may slow down wound healing and increase inflammation.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride reduces hair growth and is safe for women with excessive hair.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.